How much funding has Mirador Therapeutics raised?

Mirador Therapeutics has raised $650.0M in total funding, most recently a Series B round.

Who are Mirador Therapeutics's investors?

Mirador Therapeutics's investors include ARCH Venture Partners, OrbiMed, Innovation Endeavors, Janus Henderson Investors, Regeneron Pharmaceuticals, Point72 Ventures.

When was Mirador Therapeutics founded?

Mirador Therapeutics was founded in 2024.

Where is Mirador Therapeutics headquartered?

Mirador Therapeutics is headquartered in San Diego, California, United States.

What industry is Mirador Therapeutics in?

Mirador Therapeutics operates in Biotech, Drug Discovery, Genomics, Therapeutics.

How many employees does Mirador Therapeutics have?

Mirador Therapeutics has 11-50 employees.

Mirador Therapeutics

A new vantage point on inflammation and fibrosis

San Diego, United States · Founded 2024 · $650.0M raised

Headquarters: San Diego, California
Employees: 11–50
Founded: 2024
Business Model: B2B

Website: miradortx.com
Total Funding: $650.0M
Last Round: $250.0M Series BOct 2025
Rounds: 2

About

Mirador Therapeutics is a clinical-stage precision medicine company developing targeted therapies for immune-mediated inflammatory and fibrotic diseases. Using Mirador360™, an integrated platform with multi-modal data, AI, and advanced analytics, it identifies novel targets and optimal therapies to accelerate pipeline development.

Summary

Mirador Therapeutics is a Biotech company based in San Diego, United States, founded in 2024. It has raised $650.0M in total across 2 rounds, most recently a $250.0M Series B round in Oct 2025. Investors include ARCH Venture Partners, OrbiMed and Innovation Endeavors.